1 min read

Scrambled Gene Caused Deafness. One Injection Restored Hearing.

One gene. One injection. Silence, gone. Half of these patients now hear at normal levels.

Forty-two people were born unable to hear a single sound. Their inner ears were structurally intact; one gene was just wrong. A new trial out of China, now the largest and longest of its kind, gave each of them a single injection of corrected genetic material, and 90 percent showed marked improvements in hearing over the next several years.

The culprit is a mutation in a gene called OTOF, which produces a protein the inner ear needs to convert sound into nerve signals. The trial involved 42 participants across eight sites in China, mostly children but also three adults, all starting with complete hearing loss. The therapy delivers a working copy of the OTOF gene directly into the inner ear. Most participants saw improvement within weeks of treatment, with continued gains over time. No serious treatment-related side effects were reported.

By the study's end at 2.5 years, more than half had reached normal hearing levels. The children improved more than the adults did, but the results suggest adults can benefit too. The OTOF mutation accounts for a small fraction of inherited deafness cases, but the research team is already adapting the platform to target GJB2, the most common cause of genetic hearing loss.

After two and a half years, more than half of the participants could hear a whisper.

Read the full story at Live Science, April 22, 2026


Hot Take: The part where parents watched their kids respond to sound for the first time within weeks of a single injection is the kind of thing that makes you forgive medicine for every time it said "we're not sure yet." A body that can be reprogrammed with one corrected instruction, years after birth, is the plot twist nobody's giving enough credit for.

Subscribe to our newsletter.

Be the first to know - subscribe today